Rationale: Tick paralysis has not been reported in horses in North America.
| CASES
A 3-year-old 93.6-kg American Miniature horse filly (Horse 1) was referred in May 2018 to the Purdue University Veterinary Teaching Hospital (PUVTH) for recumbency. The owner reported the horse had 12 hours of difficulty walking and weakness that progressed to recumbency. The filly had no known vaccination history and was housed with another female American Miniature horse (Horse 2) in a heavily wooded pasture. Both horses had been purchased from a nonlicensed petting zoo 9 days before the onset of clinical signs, where they had been housed on pasture and fed round bale grass hay. They were evaluated by the referring veterinarian approximately 4 hours before presentation, and did not receive medication at that time. On examination at the PUVTH, Horse 1 was recumbent in the trailer and unable to rise (grade 5/5 gait deficit). 1 The horse was bright, alert, and responsive but anorexic with a body condition score (BCS) of 7/9. Rectal temperature was 37.8 C (reference range, 37.2 C-38.6 C), heart rate was 80 beats/min (reference range, 28-40 beats/min), and respiratory rate was 30 breaths/min (reference range, 8-20 breaths/min). In addition to recumbency, the filly also had decreased tongue and tail muscle tone. Aside from decreased tongue muscle tone, the cranial nerve Both horses were discharged with instructions to remove them from the wooded area at home and to implement tick control measures. Both horses were reported to be normal 1 week and 8 months after discharge from the hospital.
| DISCUSSION
Tick paralysis most frequently is reported in dogs, but can cause disease in humans, cats, cattle, sheep, and horses. ticks are removed compared to that caused by Dermacentor spp. in North America. 4 Tick paralysis generally occurs in the spring and summer months when ticks are actively seeking hosts, which is consistent with the cases described here. A single tick can cause clinical signs of tick paralysis in dogs, and increasing numbers of ticks are associated with increased severity of clinical signs. 15 Cases of tick paralysis in large animals have also been reported, but only in Australia. The typical presentation of large animals with tick paralysis is similar to that in small animals and consists of paresis progressing to recumbency over hours to days after tick attachment, as well as abnormal phonation and cranial nerve dysfunction. 16 In a retrospective study of 103 horses in Australia with presumptive tick paralysis secondary to I. holocyclus, 88% of the horses were recumbent and unable to stand on presentation. 17 Recumbency for >120 hours increased the odds of nonsurvival, which is not surprising given that recumbency in large animals can exacerbate morbidity secondary to decubital ulceration, intertrigo, corneal ulceration, and rhabdomyolysis. [17] [18] [19] [20] Seventy-six percent of horses were <1 year of age with over half <6 months of age, and 39% were Miniature horses or ponies. Other studies also have found that affected animals tend to be young and have relatively low body weight (eg, calves, foals, and sheep), suggesting that a high tick burden to body mass ratio might be important in whether or not clinical signs develop. 3, 6, 8 However, no association has been identified between the number of ticks (range, 1-100 ticks) found on a horse and survival. 17 This observation suggests that whereas body size might be important, other factors such as immune status (eg, naive immunity in younger animals) and tick virulence factors are also likely important in determining susceptibility to disease. In fact, only 1 to 2 ticks were identified on 63% of horses with presumptive tick paralysis. Given that both horses presented with nearly identical and acute clinical signs within the same time period, toxicosis was suspected.
Detection of numerous embedded and engorged ticks made tick paralysis likely, although botulism could not be ruled out as a cause of decreased muscle tone, weakness, and recumbency. The horses had been fed with round bale grass hay, which is a known risk factor for botulism. 19 Given the insensitivity of available antemortem diagnostic tests for botulism and the importance of rapid treatment, trivalent equine botulinum antitoxin was given to both horses within hours of presentation. 21 However, the rapid improvement in neurologic status observed in these 2 horses made botulism unlikely because recovery requires regeneration of new motor end plates, which can take up to 3 weeks. 22 Neurotoxicity associated with ingestion of locoweed, yel- Both horses reported here showed rapid improvement upon tick removal and survived. Neither horse had residual neurologic deficits.
Given the lack of published reports on tick paralysis in horses in North America, it is likely that horses are relatively resistant to the development of clinical signs. Because the prognosis for tick paralysis associated with Dermacentor spp. generally is better than that associated with Ixodes spp. in small animals, it is likely that prognosis also is favorable in horses, even with a heavy infestation. The survival rate for horses with tick paralysis caused by I. holocyclus was found to be 74%
in a large retrospective study, and if host factors that play a role in the pathophysiology of tick paralysis are shared among mammalian species, it is reasonable to expect an even better prognosis for tick paralysis associated with Dermacentor spp. 17 To summarize, tick paralysis in horses has not been recognized previously in North America. However, a thorough physical examination with a focus on the integument to identify the presence of ticks should be performed in horses presented with acute-onset ataxia or tetraparesis progressing to recumbency. Further research is needed to elucidate the mechanism of action and neuroanatomical target or targets of the Dermacentor spp. neurotoxins in horses with tick paralysis.
Additional reporting of presumptive tick paralysis in horses would better clarify the clinical course and confirm the assumption that prognosis is favorable in affected horses.
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